Rankings
▼
Calendar
ARGX Q4 2019 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$45B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+258.2% YoY
Gross Profit
-$88M
-281.5% margin
Operating Income
-$124M
-396.6% margin
Net Income
-$118M
-376.7% margin
EPS (Diluted)
$-2.99
Cash Flow
Operating Cash Flow
-$94M
Free Cash Flow
-$95M
Stock-Based Comp.
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$9M
+258.2%
Gross Profit
-$88M
-$41M
-117.4%
Operating Income
-$124M
-$56M
-119.8%
Net Income
-$118M
-$47M
-153.1%
← Q2 2019
All Quarters
Q2 2020 →